b'<style type="text/css">\r\n\t\t\t.cs2E86D3A6{text-align:center;text-indent:0pt;margin:0pt 0pt 0pt 0pt}\r\n\t\t\t.cs5925EB86{color:#000000;background-color:transparent;font-family:\'Century Schoolbook\';font-size:10pt;font-weight:bold;font-style:normal;}\r\n\t\t\t.cs95E872D0{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt}\r\n\t\t\t.csDD5E5F52{color:#000000;background-color:transparent;font-family:\'Century Schoolbook\';font-size:10pt;font-weight:normal;font-style:normal;}\r\n\t\t\t.csED7826F6{color:#000000;background-color:transparent;font-family:\'Century Schoolbook\';font-size:14pt;font-weight:bold;font-style:italic;}\r\n\t\t\t.csE0B838BE{text-align:justify;text-indent:-86pt;margin:0pt 0pt 0pt 86pt}\r\n\t\t\t.csA16174BA{color:#000000;background-color:transparent;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;}\r\n\t\t\t.cs9224F58F{text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:12pt;mso-line-height-rule:exactly}\r\n\t\t\t.csC970676{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:12pt;mso-line-height-rule:exactly}\r\n\t\t\t.cs5ADD8C59{color:#000000;background-color:transparent;font-family:\'Century Schoolbook\';font-size:9pt;font-weight:normal;font-style:normal;}\r\n\t\t\t.csE2DB38B2{color:#000000;background-color:transparent;font-family:\'Century Schoolbook\';font-size:9pt;font-weight:bold;font-style:italic;}\r\n\t\t\t.cs5D3E032C{color:#000000;background-color:transparent;font-family:\'Century Schoolbook\';font-size:9pt;font-weight:normal;font-style:normal;text-decoration: line-through;}\r\n\t\t\t.cs41ED3027{text-align:center;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:12pt;mso-line-height-rule:exactly}\r\n\t\t\t.csE3E0FE0B{color:#000000;background-color:transparent;font-family:\'Century Schoolbook\';font-size:10pt;font-weight:normal;font-style:italic;}\r\n\t\t\t.cs5CA3ADAD{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 54pt;line-height:12pt;mso-line-height-rule:exactly}\r\n\t\t\t.csF0A1D375{text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.5}\r\n\t\t\t.cs22FF6315{color:#000000;background-color:transparent;font-family:\'Century Schoolbook\';font-size:10pt;font-weight:bold;font-style:italic;}\r\n\t\t\t.cs98AF35F2{color:#000000;background-color:transparent;font-family:\'Century Schoolbook\';font-size:10pt;font-weight:normal;font-style:normal;text-decoration: line-through;}\r\n\t\t</style>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\r\n\r\n\t\t<p class="cs2E86D3A6"><span class="cs5925EB86">SB 45 - AS AMENDED BY THE HOUSE</span></p><p class="cs2E86D3A6"><span class="cs5925EB86">&nbsp;</span></p><p class="cs95E872D0"><span class="csDD5E5F52">02/11/2021 &nbsp;&nbsp;0167s</span></p><p class="cs95E872D0"><span class="csDD5E5F52">3Jun2021... 1253h</span></p><p class="cs2E86D3A6"><span class="csDD5E5F52">2021 SESSION</span></p><p class="cs95E872D0" style="tab-stops:left 396pt;"><span class="csDD5E5F52">\t21-0834</span></p><p class="cs95E872D0" style="tab-stops:left 396pt;"><span class="csDD5E5F52">\t10/05</span></p><p class="cs95E872D0"><span class="csDD5E5F52">&nbsp;</span></p><p class="cs95E872D0" style="tab-stops:left 108pt;"><span class="csDD5E5F52">SENATE BILL\t</span><span class="csED7826F6">45</span></p><p class="cs95E872D0"><span class="csDD5E5F52">&nbsp;</span></p><p class="csE0B838BE"><span class="csDD5E5F52">AN ACT\t</span><a name="bkTitleDraft0"><span class="csDD5E5F52">relative to the controlled drug prescription health and safety program.</span></a></p><p class="cs95E872D0"><span class="csDD5E5F52">&nbsp;</span></p><p class="csE0B838BE" style="tab-stops:left 86.45pt;"><span class="csDD5E5F52">SPONSORS:\tSen. Giuda, Dist 2; Sen. Soucy, Dist 18; Sen. Carson, Dist 14; Sen. Prentiss, Dist 5; Rep. M. Pearson, Rock. 34; Rep. Marsh, Carr. 8; Rep. Merchant, Sull. 4</span></p><p class="cs95E872D0"><span class="csDD5E5F52">&nbsp;</span></p><p class="csE0B838BE" style="tab-stops:left 86.45pt;"><span class="csDD5E5F52">COMMITTEE:\tHealth and Human Services</span></p><p class="cs95E872D0" style="tab-stops:left 90pt;"><span class="csDD5E5F52">&nbsp;</span></p><p class="cs95E872D0" style="tab-stops:left 90pt;"><span class="csA16174BA">-----------------------------------------------------------------</span></p><p class="cs95E872D0" style="tab-stops:left 90pt;"><span class="csDD5E5F52">&nbsp;</span></p><p class="cs2E86D3A6"><span class="csDD5E5F52">AMENDED ANALYSIS</span></p><p class="cs95E872D0"><span class="csDD5E5F52">&nbsp;</span></p><p class="cs9224F58F" style="tab-stops:left 18pt left 86.45pt;"><span class="csDD5E5F52">\tThis bill modifies requirements for participation in and sharing of information from the controlled drug prescription health and safety program.</span></p><p class="cs95E872D0"><span class="csDD5E5F52">&nbsp;</span></p><p class="cs95E872D0"><span class="csDD5E5F52">- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - </span></p><p class="cs95E872D0"><span class="csDD5E5F52">&nbsp;</span></p><p class="csC970676" style="tab-stops:left 14.4pt left 82.8pt;"><span class="cs5ADD8C59">Explanation:\tMatter added to current law appears in </span><span class="csE2DB38B2">bold italics.</span></p><p class="csC970676" style="tab-stops:left 14.4pt left 82.8pt;"><span class="cs5ADD8C59">\t\tMatter removed from current law appears [</span><span class="cs5D3E032C">in brackets and struckthrough.</span><span class="cs5ADD8C59">]</span></p><p class="csC970676" style="tab-stops:left 14.4pt left 82.8pt;"><span class="cs5ADD8C59">\t\tMatter which is either (a) all new or (b) repealed and reenacted appears in regular type.</span></p><p class="csC970676" style="tab-stops:left 396pt;"><span class="csDD5E5F52">02/11/2021 &nbsp;&nbsp;0167s</span></p><p class="csC970676" style="tab-stops:left 396pt;"><span class="csDD5E5F52">3Jun2021... 1253h\t21-0834</span></p><p class="csC970676" style="tab-stops:left 396pt;"><span class="csDD5E5F52">\t10/05</span></p><p class="cs95E872D0"><span class="csDD5E5F52">&nbsp;</span></p><p class="cs41ED3027" style="tab-stops:left 396pt;"><span class="csDD5E5F52">STATE OF NEW HAMPSHIRE</span></p><p class="cs41ED3027" style="tab-stops:left 396pt;"><span class="csDD5E5F52">&nbsp;</span></p><p class="cs41ED3027" style="tab-stops:left 396pt;"><span class="csE3E0FE0B">In the Year of Our Lord Two Thousand Twenty One</span></p><p class="csC970676" style="tab-stops:left 396pt;"><span class="csDD5E5F52">&nbsp;</span></p><p class="csE0B838BE"><span class="csDD5E5F52">AN ACT\t</span><a name="_dx_frag_StartFragment"></a><a name="_dx_frag_EndFragment"></a><a name="bkTitleDraft1"><span class="csDD5E5F52">relative to the controlled drug prescription health and safety program.</span></a></p><p class="cs5CA3ADAD" style="tab-stops:left 396pt;"><span class="csDD5E5F52">&nbsp;</span></p><p class="cs41ED3027" style="tab-stops:left 396pt;"><span class="csE3E0FE0B">Be it Enacted by the Senate and House of Representatives in General Court convened:</span></p><p class="cs41ED3027" style="tab-stops:left 396pt;"><span class="csDD5E5F52">&nbsp;</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t</span><a name="Chapt3"></a><span class="csDD5E5F52">1 &nbsp;Controlled Drug Prescription Health and Safety Program; Definitions. &nbsp;Amend RSA 318-B:31, IV to read as follows:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\tIV. &nbsp;&quot;Dispenser&quot; means a person or entity who is lawfully authorized to deliver a schedule II-IV controlled substance, but does not include: </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\t\t(a) &nbsp;A licensed hospital pharmacy </span><span class="cs22FF6315">under RSA 318 </span><span class="csDD5E5F52">that dispenses less than a 48-hour supply of a schedule II-IV controlled substance from a hospital emergency department or that dispenses for administration in the hospital; </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\t\t(b) &nbsp;A practitioner, or other authorized person who administers such a substance; </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\t\t(c) &nbsp;A wholesale distributor of a schedule II-IV controlled substance or its analog; </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\t\t(d) &nbsp;A prescriber who dispenses less than a 48-hour supply of a schedule II-IV controlled substance from a hospital emergency department to a patient; [</span><span class="cs98AF35F2">or</span><span class="csDD5E5F52">] </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\t\t(e) &nbsp;A veterinarian who dispenses less than a 48-hour supply of a schedule II-IV controlled substance to a patient</span><span class="cs22FF6315">; or</span><span class="csDD5E5F52"> </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="cs22FF6315">\t\t\t(f)  A practitioner who does not hold or operate under an active Drug Enforcement Agency registration number to prescribe or dispense controlled substances.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t</span><a name="Chapt4"></a><span class="csDD5E5F52">2 &nbsp;New Paragraph; Controlled Drug Prescription Health and Safety Program; Information. &nbsp;Amend RSA 318-B:32 by inserting after paragraph I the following new paragraph:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\tI-a. &nbsp;The office may enter into agreements or contracts to facilitate the confidential sharing of information relating to the prescribing and dispensing of schedule II-IV controlled substances, by practitioners within the state and to establish secure connections between the program and a practitioner&rsquo;s electronic health record keeping system. &nbsp;An electronic health record keeping system may allow for the query and retrieval of the provider specified, individual&#39;s program information for display and retention in the patient&rsquo;s medical information; provided that nothing in this section shall allow the electronic health record keeping system owner or license holder to perform data queries unrelated to individuals under the practitioner&#39;s care. &nbsp;The electronic health record keeping system owner or license holder shall be responsible for ensuring that only authorized individuals have access to program information. &nbsp;The program shall record and retain in its database what information was transferred and the identity of the organization who received the information. &nbsp;The program shall include this information when a patient requests a report pursuant to RSA 318-B:35, I(b)(1).</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t</span><a name="Chapt14"></a><span class="csDD5E5F52">3 &nbsp;New Paragraph; Controlled Drug Prescription Health and Safety Program; Confidentiality. &nbsp;Amend RSA 318-B:34 by inserting after paragraph II the following new paragraph: </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\tII-a. &nbsp;A practitioner who intends to request and use information from the program about a patient shall post a sign that can be easily viewed by the public that discloses to the public that the practitioner may access and use information contained in the program. &nbsp;In lieu of posting a sign, the practitioner may provide such notice in written material provided to the patient.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t</span><a name="Chapt13"></a><span class="csDD5E5F52">4 &nbsp;Providing Controlled Drug Prescription Health and Safety Information. &nbsp;Amend RSA 318-B:35, I(a)(2) and (3) to read as follows:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\t\t\t(2) &nbsp;For reviewing information regarding prescriptions issued or dispensed </span><span class="cs22FF6315">or for conducting medication reconciliation </span><span class="csDD5E5F52">by the requester; [</span><span class="cs98AF35F2">or</span><span class="csDD5E5F52">] </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\t\t\t(3) &nbsp;For the purpose of investigating the death of an individual</span><span class="cs22FF6315">; or</span><span class="csDD5E5F52"> </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\t\t\t(</span><span class="cs22FF6315">4) &nbsp;For the purpose of administering RSA 318:29-a, VI, RSA 326-B:36-a, RSA 329:13-b, and other participating health professional boards</span><span class="csDD5E5F52">.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t</span><a name="Chapt12"></a><span class="csDD5E5F52">5 &nbsp;Repeal. &nbsp;RSA 318-B:35, I(b)(5), relative to a practitioner or consultant retained by the office of professional licensure and certification to review certain information, is repealed.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t</span><a name="Chapt11"></a><span class="csDD5E5F52">6 &nbsp;Contingent Version; Controlled Drug Prescription Health and Safety Program; Definitions. &nbsp;Amend RSA 126-A:89, VI to read as follows:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\tVI. &nbsp;&quot;Dispenser&quot; means a person or entity who is lawfully authorized to deliver a schedule II-IV controlled substance, but does not include: </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\t\t(a) &nbsp;A licensed hospital pharmacy </span><span class="cs22FF6315">under RSA 318 </span><span class="csDD5E5F52">that dispenses less than a 48-hour supply of a schedule II-IV controlled substance from a hospital emergency department or that dispenses for administration in the hospital; </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\t\t(b) &nbsp;A practitioner, or other authorized person who administers such a substance; </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\t\t(c) &nbsp;A wholesale distributor of a schedule II-IV controlled substance or its analog; </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\t\t(d) &nbsp;A prescriber who dispenses less than a 48-hour supply of a schedule II-IV controlled substance from a hospital emergency department to a patient; [</span><span class="cs98AF35F2">or</span><span class="csDD5E5F52">]</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\t\t(e) &nbsp;A veterinarian who dispenses less than a 48-hour supply of a schedule II-IV controlled substance to a patient; </span><span class="cs22FF6315">or</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\t</span><span class="cs22FF6315">\t(f)  A practitioner who does not hold or operate under an active Drug Enforcement Agency registration number to prescribe or dispense controlled substances.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t</span><a name="Chapt10"></a><span class="csDD5E5F52">7  Contingent Version; New Paragraph; Controlled Drug Prescription Health and Safety Program; Information. &nbsp;Amend RSA 126-A:90 by inserting after paragraph I the following new paragraph:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\tI-a.  The department may enter into agreements or contracts to facilitate the confidential sharing of information relating to the prescribing and dispensing of schedule II-IV controlled substances, by practitioners within the state and to establish secure connections between the program and a practitioner&rsquo;s electronic health record keeping system. &nbsp;An electronic health record keeping system may allow for the query and retrieval of the provider specified, individual&#39;s program information for display and retention in the patient&rsquo;s medical information; provided that nothing in this section shall allow the electronic health record keeping system owner or license holder to perform data queries unrelated to individuals under the practitioner&#39;s care. &nbsp;The electronic health record keeping system owner or license holder shall be responsible for ensuring that only authorized individuals have access to program information.  The program shall record and retain in its database what information was transferred and the identity of the organization who received the information. &nbsp;The program shall include this information when a patient requests a report pursuant to RSA 126-A:93, I(b)(1).</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t</span><a name="Chapt5"></a><span class="csDD5E5F52">8 &nbsp;Contingent Version; New Paragraph; Controlled Drug Prescription Health and Safety Program; Confidentiality. &nbsp;Amend RSA 126-A:92 by inserting after paragraph II the following new paragraph: </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\tII-a. &nbsp;A practitioner who intends to request and use information from the program about a patient shall post a sign that can be easily viewed by the public that discloses to the public that the practitioner may access and use information contained in the program. &nbsp;In lieu of posting a sign, the practitioner may provide such notice in written material provided to the patient.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t</span><a name="Chapt6"></a><span class="csDD5E5F52">9 &nbsp;Contingent Version; Providing Controlled Drug Prescription Health and Safety Information. &nbsp;Amend RSA 126-A:93, I(a)(2) and (3) to read as follows:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\t\t\t(2) &nbsp;For reviewing information regarding prescriptions issued or dispensed </span><span class="cs22FF6315">or for conducting medication reconciliation</span><span class="csDD5E5F52"> by the requester; [</span><span class="cs98AF35F2">or</span><span class="csDD5E5F52">] </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\t\t\t(3) &nbsp;For the purpose of investigating the death of an individual</span><span class="cs22FF6315">; or</span><span class="csDD5E5F52"> </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\t\t\t(</span><span class="cs22FF6315">4) &nbsp;For the purpose of administering RSA 318:29-a, VI, RSA 326-B:36-a, RSA 329:13-b, and other participating health professional boards</span><span class="csDD5E5F52">.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t</span><a name="Chapt9"></a><span class="csDD5E5F52">10 &nbsp;Contingent Version; Repeal. &nbsp;RSA 126-A:93, I(b)(4), relative to a practitioner or consultant retained by the department of health and human services to review certain information, is repealed.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t</span><a name="Chapt8"></a><span class="csDD5E5F52">11 &nbsp;Contingency. &nbsp;</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\tI. &nbsp;If HB 2-FN-A-L of the 2021 legislative session becomes law and contains provisions transferring the administration of the controlled drug prescription health and safety program from the office of professional licensure and certification under RSA 318-B to the department of health and human services under RSA 126-A, then sections 1-5 of this act shall take effect upon its passage and until July 1, 2021 and then sections 6-10 of this act shall take effect July 1, 2021 at 12:01 a.m. </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\tII. &nbsp;If HB 2-FN-A-L of the 2021 legislative session becomes law and does not contain provisions transferring the administration of the controlled drug prescription health and safety program from the office of professional licensure and certification under RSA 318-B to the department of health and human services under RSA 126-A, or if HB 2 FN-A-L does not become law, then sections 6-10 of this act shall not take effect and sections 1-5 of this act shall take effect upon its passage. </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t</span><a name="Chapt7"></a><span class="csDD5E5F52">12 &nbsp;Effective Date. &nbsp;</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\tI. &nbsp;Sections 1-10 of this act shall take effect as provided in section 11 of this act. </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">\t\tII. &nbsp;The remainder of this act shall take effect upon its passage.</span></p>'